Agendia
Molecular diagnostics and personalized treatment plans for cancer patients
Agendia has raised €65M across 2 funding rounds from 1 investor, most recently a Series D+ round in May 2012. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Amsterdam, Netherlandsagendia.com ↗
Total raised
€65M
€65,305,724
Funding rounds
2
Investors
1
distinct backers
Active since
2009-09
latest 2012-05
Funding by year
EUR raised per yearAgendia — funding by year — interactive chart.
Data table
| Agendia — funding by year | |
|---|---|
| 2009 | €16M |
| 2012 | €49M |
Signals
High confidenceRaise-next likelihood11
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (17y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-05-01 | Series D+ | €49M | ING Bank Corporate Finance | View deal → |
| 2009-09-01 | Growth/Late | €16M | ING Bank Corporate Finance | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData